INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStromâ„¢ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
Go back to INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStromâ„¢ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases| (NASDAQ: INMB) | Delayed: 1.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.43 | EPS | $ | |||
| Volume | 2,159 | |||||

